Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release

BACKGROUND AND PURPOSE: The ability of the muscarinic cholinergic antagonist atropine to inhibit myopia development in humans and animal models would suggest that cholinergic hyperactivity may underlie myopic growth. To test this, we investigated whether cholinergic agonists accelerate ocular growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomson, Kate, Kelly, Tamsin, Karouta, Cindy, Morgan, Ian, Ashby, Regan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293064/
https://www.ncbi.nlm.nih.gov/pubmed/34302355
http://dx.doi.org/10.1111/bph.15629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293064/
https://www.ncbi.nlm.nih.gov/pubmed/34302355
http://dx.doi.org/10.1111/bph.15629

Ejemplares similares